BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim D, Pollock C. Epidemiology and burden of chronic kidney disease-associated pruritus. Clin Kidney J 2021;14:i1-7. [PMID: 34987777 DOI: 10.1093/ckj/sfab142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, Jha V, Makusidi MA, Mcculloch M, Shah N, Wainstein M, Johnson DW. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. [DOI: 10.1038/s41581-022-00623-7] [Reference Citation Analysis]
2 Fugal J, Serpa SM. Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus. Ann Pharmacother 2022;:10600280221115889. [PMID: 35942600 DOI: 10.1177/10600280221115889] [Reference Citation Analysis]
3 Wala K, Szepietowski JC. Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review. Pharmaceuticals 2022;15:934. [DOI: 10.3390/ph15080934] [Reference Citation Analysis]